Fischer B
Department of Public Health Sciences, University of Toronto.
J Public Health Policy. 2000;21(2):187-210.
Illicit opiate addiction has emerged as a major problem in many Western countries in the second half of this century, and its social harm implications have become much exacerbated with the onset of the HIV epidemic in the 1980s. By now, most Western jurisdictions have resorted to methadone treatment as the most effective and best researched intervention against the negative consequences of opiate addiction including mortality, morbidity, crime, and loss of social functioning. Methadone treatment in Canada features a long, turbulent, and instructive history as an exemplary case study in public policy. While both Britain and the U.S. experimented with opiate prescription treatment in the first half of the century, Canadian proposals for such programs initially never made it beyond the discussion stage, largely due to the influential resistance from the law enforcement sector. However, in light of growing influence from an emerging addictions treatment sector, Canada became the first Western jurisdiction to experiment with methadone prescription for the treatment of opiate addiction forty years ago. Methadone treatment became quickly and widely established as an effective treatment modality through the 1960s. But in the early 1970s, resistance from the law and health sectors evolved, and triggered the government to establish a set of comprehensive and restrictive federal methadone treatment regulations, which have dominated its realities until today. Almost completely regulated out of existence by the end of the 1970s, methadone treatment's prevalence gradually increased again through the 1980s, and recent decentralization efforts to provincial levels earlier this decade have had dramatic effects on treatment availability. Significant events in the Canadian history of methadone treatment and its regulation reflect developments in the U.S., and substantial recent domestic treatment expansion developments--as well as renewed sparks of resistance--are reminiscent of methadone treatment's patterns of history as they developed in the late 1960s. This paper traces the turbulent history of methadone treatment, regulation and policy in Canada with particular attention to institutional, professional and political determinants at the complex intersection of health, law, and addiction.
非法阿片类药物成瘾在本世纪下半叶已成为许多西方国家的一个主要问题,随着20世纪80年代艾滋病流行的出现,其对社会的危害影响变得更加严重。到目前为止,大多数西方司法管辖区已采用美沙酮治疗作为针对阿片类药物成瘾的负面后果(包括死亡率、发病率、犯罪和社会功能丧失)最有效且研究最充分的干预措施。加拿大的美沙酮治疗有着漫长、波折且具有启发性的历史,是公共政策方面一个典型的案例研究。虽然英国和美国在本世纪上半叶都曾尝试过阿片类药物处方治疗,但加拿大此类项目的提议最初从未超出讨论阶段,主要是由于执法部门的强大阻力。然而,鉴于新兴的成瘾治疗部门影响力不断增强,四十年前加拿大成为首个尝试使用美沙酮处方治疗阿片类药物成瘾的西方司法管辖区。在整个20世纪60年代,美沙酮治疗迅速且广泛地成为一种有效的治疗方式。但在20世纪70年代初,法律和卫生部门的阻力出现变化,并促使政府制定了一套全面且严格的联邦美沙酮治疗法规,这些法规至今仍主导着实际情况。到20世纪70年代末,美沙酮治疗几乎完全因监管而不复存在,其普及率在20世纪80年代又逐渐上升,并且本十年初最近将权力下放到省级层面的举措对治疗可及性产生了巨大影响。加拿大美沙酮治疗及其监管历史上的重大事件反映了美国的发展情况,近期国内治疗大幅扩张的发展情况以及新出现的阻力火花,让人想起20世纪60年代末美沙酮治疗的发展模式。本文追溯了加拿大美沙酮治疗、监管和政策的波折历史,特别关注健康、法律和成瘾这一复杂交叉领域的制度、专业和政治决定因素。